Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cyproterone acetate preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Some |
|
Cyproterone acetate [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Some |
|
Cyproterone acetate 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Some |
|
Cyproterone acetate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Some |
|
Cyproterone acetate [acne] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Some |
|
Cyproterone acetate and ethinylestradiol adverse reaction |
Causative agent (attribute) |
False |
Cyproterone acetate |
Inferred relationship |
Some |
2 |
Allergy to cyproterone acetate and ethinylestradiol |
Causative agent (attribute) |
False |
Cyproterone acetate |
Inferred relationship |
Some |
|
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Some |
|
Product containing cyproterone acetate and ethinyl estradiol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Some |
|
Cyproterone acetate 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Some |
1 |
Cyproterone acetate 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyproterone acetate |
Inferred relationship |
Some |
1 |
Cyproterone acetate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Some |
1 |
Cyproterone acetate 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyproterone acetate |
Inferred relationship |
Some |
1 |
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyproterone acetate |
Inferred relationship |
Some |
2 |
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cyproterone acetate |
Inferred relationship |
Some |
2 |
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cyproterone acetate |
Inferred relationship |
Some |
1 |
Allergy to cyproterone acetate and ethinylestradiol |
Causative agent (attribute) |
False |
Cyproterone acetate |
Inferred relationship |
Some |
1 |
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Cyproterone acetate |
Inferred relationship |
Some |
1 |
Cyproterone acetate 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyproterone acetate |
Inferred relationship |
Some |
1 |
Cyproterone acetate 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyproterone acetate |
Inferred relationship |
Some |
1 |
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cyproterone acetate |
Inferred relationship |
Some |
2 |